Pancreatic Cancer Research

ResearcherUniversity of ToledoActive in the last 2 years

Jingyuan Liu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-6771-8496; OpenAlex author ID A5048602952. Sources: OpenAlex.

Their work

Papers
3 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
8
Papers, trials and grants by year

2024: 1 paper · 2025: 2 papers

Papers 3

  1. Gap-App: A sex-distinct AI-based predictor for pancreatic ductal adenocarcinoma survival as a web application open to patients and physicians. Last author DOI 10.1016/j.canlet.2025.217689↗
  2. A PP2A-mtATR-tBid axis links DNA damage-induced CIP2A degradation to apoptotic dormancy and therapeutic resistance in PDAC. Co-author DOI 10.1016/j.canlet.2025.217790↗
  3. Smart exosomes enhance PDAC targeted therapy. Co-author DOI 10.1016/j.jconrel.2024.02.037↗

Closest collaborators

The 8 strongest of 8 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Shi‐He Liu · 2 shared papers, 2024–2025 · strength 0.47
  2. Anuj Ojha · 1 shared paper, 2025 · strength 0.30
  3. Yibo Luo · 1 shared paper, 2025 · strength 0.27
  4. Yue Zou · 1 shared paper, 2025 · strength 0.27
  5. Donald Rao · 1 shared paper, 2024 · strength 0.20
  6. Justin F. Creeden · 1 shared paper, 2024 · strength 0.20
  7. John J. Nemunaitis · 1 shared paper, 2024 · strength 0.20
  8. Francis Charles Brunicardi · 1 shared paper, 2024 · strength 0.20

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.